GNC Shares GMP Guidelines To Boost Compliance, Not Suggest DSHEA Reform
This article was originally published in The Pink Sheet Daily
Executive Summary
Sharing the guidelines across the industry should help firms comply with FDA's GMPs required under dietary supplement statutes, says GNC CEO Mike Archbold.
You may also be interested in...
GNC, Vitamin Shoppe Not On Same Page In Solving Similar Growth Challenges
Common thread between the manufacturers and retail chain operators offering their own and other brands extends to relatively recent executive suite shakeups following extended stretches of declining sales growth. GNC reported nearly $70m net income for 2018 after two years of net losses and Vitamin Shoppe trimmed its loss by more than $200m from 2017 to $12.1m.
GNC Supply Chain Reform Pays Dividends In DoJ Settlement From DMAA Investigation
DoJ announces a "non-prosecution agreement" that requires GNC to pay $2.25m and to cooperate in dietary supplement market investigations conducted by FDA and other federal agencies, including the current litigation against USPlabs.
Supplement Industry's Health Linked To Improving Consumer Trust
"The difficult truth that we need to face," says Eric Pierce, New Hope Network's strategy and insights director, is that most consumers don't trust the supplement industry.